Aberdeen Asset Management’s Teladoc Health TDOC Stock Holding History

Aberdeen Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-107,100	Closed	-$1.77M	–	753
2016 Q4	$1.77M	Sell	107,100 -53,358	-33%	-$906K	0.01%	584
2016 Q3	$2.94M	Buy	+160,458	New	+$2.81M	0.01%	526
2016 Q2	–	Sell	-14,136	Closed	-$136K	–	731
2016 Q1	$136K	Buy	+14,136	New	+$201K	﹤0.01%	719

Other funds holding TDOC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Aberdeen Asset Management's TDOC Position: Q1 2017 in Review

Aberdeen Asset Management sold out of Teladoc Health (TDOC) in Q1 2017, closing a stake of 107,100 shares — an estimated $1.77M sold.

Aberdeen Asset Management first reported a position in TDOC in Q1 2016 and held it in 3 quarters. The position peaked at $2.94M in Q3 2016. 132 funds tracked by Wall St. Rank hold TDOC as of Q1 2017.

Aberdeen Asset Management reported no remaining Teladoc Health position as of Q1 2017 after selling out during the quarter.
Aberdeen Asset Management sold 107,100 Teladoc Health shares in Q1 2017, an estimated $1.77M.
Aberdeen Asset Management first reported a position in Teladoc Health in Q1 2016 and held it in 3 quarters.
Aberdeen Asset Management's Teladoc Health position peaked at $2.94M in Q3 2016.
132 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2017.

Based on Aberdeen Asset Management's 13F filing for Q1 2017, filed 10 May 2017.